Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Epizyme Inc (NASDAQ:EPZM)

7.58
Delayed Data
As of 4:00pm ET
 +0.06 / +0.80%
Today’s Change
7.36
Today|||52-Week Range
21.28
-52.68%
Year-to-Date
No recent news for Epizyme Inc.

Today’s Trading

Previous close7.52
Today’s open7.50
Day’s range7.44 - 7.80
Volume208,988
Average volume (3 months)355,142
Market cap$435.8M
Dividend yield--
Data as of 4:00pm ET, 08/30/2016

Growth & Valuation

Earnings growth (last year)-98.80%
Earnings growth (this year)+35.03%
Earnings growth (next 5 years)--
Revenue growth (last year)-93.82%
P/E ratioNM
Price/Sales249.31
Price/Book1.85

Competitors

 Today’s
change
Today’s
% change
MCRBSeres Therapeutics I...-0.12-1.10%
XBITXBiotech Inc-0.16-1.21%
GERNGeron Corp+0.03+1.13%
KDMNKadmon Holdings Inc-0.12-1.20%
Data as of 4:00pm ET, 08/30/2016

Financials

Next reporting dateOctober 18, 2016
EPS forecast (this quarter)-$0.58
Annual revenue (last year)$2.6M
Annual profit (last year)-$132.4M
Net profit margin-5,170.94%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert B. Bazemore
Chief Operating Officer
Matthew E. Ros
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Search for Jobs